BioRestorative Therapies, Inc. Common Stock (NV) (BRTX) is a publicly traded Healthcare sector company. As of July 17, 2026, BRTX trades at $0.35 with a market cap of $8.66M and a P/E ratio of -0.21. BRTX moved +8.79% today. Year to date, BRTX is -70.14%; over the trailing twelve months it is -77.94%. Its 52-week range spans $0.16 to $2.55. Rallies surfaces BRTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for BRTX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $0.35 |
| Market Cap | $8.66M |
| P/E Ratio | -0.21 |
| EPS | $-1.58 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.55 |
| 52-Week Low | $0.16 |
| Volume | 589.61K |
| Avg Volume | 0 |
| Revenue (TTM) | $359.70K |
| Net Income | $-14.24M |
| Gross Margin | 93.37% |
BRTX analyst coverage data. Average price target: $0.00.